Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis

Denosumab, a human monoclonal antibody against RANK ligand, is shown to have strong anti-fracture effects in Japanese osteoporosis patients.However, there have been no data showing actions on Japanese bone architecture.Here Vinegars we show that denosumab continuously improves several geometrical parameters calculated by hip structural analysis for

read more